Evidence map›Paper›PMID 15729590›Full record

ArticleParasitology research2005

Identification of proteins interacting with Toxoplasma SRCAP by yeast two-hybrid screening.

Karuna C Nallani, William J Sullivan

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. A decade of epigenetic research in Toxoplasma gondii.Molecular and biochemical parasitology · 2010
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Karuna C NallaniDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Medical Sciences Building Room A-525, 635 Barnhill Drive, Indianapolis, IN 46202, USA.
William J Sullivan
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Production of New Adenovector Constructs with Fiber-Shaft ModificationsZ01AI005093 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI WALLACE, KIMBERLY · 2007 to 2008
$2.7M
GENE DISCOVERY IN TOXOPLASMA GONDIIR01AI045806 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L DAVID · 2000 to 2003
$1.6M
NIAID NIH HHS AI05093NIAID NIH HHS R01 AI045806-01A1
6 · The paper itself

Abstract

Toxoplasma gondii is an opportunistic protozoan parasite that differentiates into latent cysts (bradyzoite) that can be reactivated during immunosuppression. TgSRCAP (Toxoplasma gondii Snf2-related CBP activator protein) is a SWI2/SNF2 family chromatin remodeler whose expression increases during cyst development. Identifying the proteins associating with TgSRCAP during the pre-cyst stage (tachyzoite) will increase our understanding of how parasite differentiation is initiated. We employed the yeast two-hybrid system to identify proteins that may interact directly with TgSRCAP. A stretch of 1,060 amino acids between ATPase subdomains IV and V of TgSRCAP was chosen as "bait" since the corresponding region in human SRCAP interacts with other proteins, including CREB binding protein. We have identified several novel parasite-specific transcription factors predicted to be in the T. gondii genome. Metabolic enzymes that may participate in cyst development were also identified as interacting with TgSRCAP.

Indexed as

AnimalsComputational BiologyEnzymesHumansImmunoprecipitationPlasmidsProtein BindingProtozoan ProteinsToxoplasmaTranscription FactorsTwo-Hybrid System TechniquesEnzymesProtozoan ProteinsTranscription Factors

Identifiers

PMID15729590
OpenAlexW2004188783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.